These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 17927643)

  • 1. Disability in chronic migraine with medication overuse: treatment effects at 3 years.
    Andrasik F; Grazzi L; Usai S; D'Amico D; Kass S; Bussone G
    Headache; 2007 Oct; 47(9):1277-81. PubMed ID: 17927643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disability in chronic migraine with medication overuse: treatment effects through 5 years.
    Andrasik F; Grazzi L; Usai S; Kass S; Bussone G
    Cephalalgia; 2010 May; 30(5):610-4. PubMed ID: 19614686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic migraine with medication overuse: treatment outcome and disability at 3 years follow-up.
    Usai S; Grazzi L; Andrasik F; D'Amico D; Rigamonti A; Bussone G
    Neurol Sci; 2004 Oct; 25 Suppl 3():S272-3. PubMed ID: 15549557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disability in chronic migraine patients with medication overuse: treatment effects at 1-year follow-up.
    Grazzi L; Andrasik F; D'Amico D; Usai S; Kass S; Bussone G
    Headache; 2004; 44(7):678-83. PubMed ID: 15209690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transformed migraine and medication overuse in a tertiary headache centre--clinical characteristics and treatment outcomes.
    Bigal ME; Rapoport AM; Sheftell FD; Tepper SJ; Lipton RB
    Cephalalgia; 2004 Jun; 24(6):483-90. PubMed ID: 15154858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R; Schreiber C
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decision-making deficit in chronic migraine patients with medication overuse.
    Biagianti B; Grazzi L; Gambini O; Usai S; Muffatti R; Scarone S; Bussone G
    Neurol Sci; 2012 May; 33 Suppl 1():S151-5. PubMed ID: 22644192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 3-month analysis of disability, quality of life, and disease course in patients with migraine.
    Raggi A; Leonardi M; Bussone G; D'Amico D
    Headache; 2013 Feb; 53(2):297-309. PubMed ID: 23094760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disability pattern in chronic migraine with medication overuse: a comparison with migraine without aura.
    D'Amico D; Grazzi L; Usai S; Rigamonti A; Curone M; Bussone G
    Headache; 2005 May; 45(5):553-60. PubMed ID: 15953274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Duration of migraine is a predictor for response to botulinum toxin type A.
    Eross EJ; Gladstone JP; Lewis S; Rogers R; Dodick DW
    Headache; 2005 Apr; 45(4):308-14. PubMed ID: 15836566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic daily headache in adolescents: an 8-year follow-up study.
    Wang SJ; Fuh JL; Lu SR
    Neurology; 2009 Aug; 73(6):416-22. PubMed ID: 19605771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocrine function is altered in chronic migraine patients with medication-overuse.
    Rainero I; Ferrero M; Rubino E; Valfrè W; Pellegrino M; Arvat E; Giordano R; Ghigo E; Limone P; Pinessi L
    Headache; 2006 Apr; 46(4):597-603. PubMed ID: 16643554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medication overuse headache: clinical features predicting treatment outcome at 1-year follow-up.
    Zidverc-Trajkovic J; Pekmezovic T; Jovanovic Z; Pavlovic A; Mijajlovic M; Radojicic A; Sternic N
    Cephalalgia; 2007 Nov; 27(11):1219-25. PubMed ID: 17888081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of intensive patient education on clinical outcome in a clinic-based migraine population.
    Rothrock JF; Parada VA; Sims C; Key K; Walters NS; Zweifler RM
    Headache; 2006 May; 46(5):726-31. PubMed ID: 16643574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum Toxin Type A in the treatment of chronic migraine without medication overuse.
    Freitag FG; Diamond S; Diamond M; Urban G
    Headache; 2008 Feb; 48(2):201-9. PubMed ID: 18042229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional-MRI evaluation of pain processing in chronic migraine with medication overuse.
    Chiapparini L; Grazzi L; Ferraro S; Mandelli ML; Usai S; Andrasik F; Bruzzone MG; Bussone G
    Neurol Sci; 2009 May; 30 Suppl 1():S71-4. PubMed ID: 19415430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Headache prophylaxis with BoNTA: patient characteristics.
    Silberstein SD; Marmura MJ; Shaw J; Yu S
    Headache; 2010 Jan; 50(1):63-70. PubMed ID: 19549156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Similarities and differences between chronic migraine and episodic migraine.
    Ferrari A; Leone S; Vergoni AV; Bertolini A; Sances G; Coccia CP; Ottani A; Pinetti D; Sternieri E
    Headache; 2007 Jan; 47(1):65-72. PubMed ID: 17355496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of early intervention with almotriptan vs placebo on migraine-associated functional disability: results from the AEGIS Trial.
    Freitag F; Smith T; Mathew N; Rupnow M; Greenberg S; Mao L; Finlayson G; Wright P; Biondi D;
    Headache; 2008 Mar; 48(3):341-54. PubMed ID: 18302700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIT-6 and MIDAS as measures of headache disability in a headache referral population.
    Sauro KM; Rose MS; Becker WJ; Christie SN; Giammarco R; Mackie GF; Eloff AG; Gawel MJ
    Headache; 2010 Mar; 50(3):383-95. PubMed ID: 19817883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.